Insightful Science Acquires Omiq Inc

Insightful Science Acquires Dotmatics

March 22, 2021

Cloud & SaaS

Insightful Science, a PE-backed life sciences software company, has entered into a transaction to acquire Dotmatics, a cloud-first scientific R&D data management and informatics SaaS provider. The combined company will create an end-to-end, cloud-first scientific research platform aimed at improving lab efficiency and accelerating discovery across pharmaceuticals, biotechnology, chemicals and materials industries.

Insightful Science Acquires Protein Metrics

December 21, 2021

Software

Insightful Science, a portfolio company of Insight Partners, has acquired Protein Metrics, a provider of protein characterization and proteomics analysis software. The deal adds proteomics capabilities to Insightful Science's R&D software portfolio (including GraphPad Prism, SnapGene, Geneious Prime and Dotmatics) to help biopharma and research customers accelerate protein analysis across research and production.

Insightful Science Acquires De Novo Software (FCS Express)

September 14, 2021

Software

Insightful Science, a PE-backed scientific software platform, has acquired De Novo Software, the maker of FCS Express, a leading flow cytometry data analysis solution. The deal adds flow cytometry capabilities to Insightful Science's Cloud for Scientific Discovery platform, expanding its offerings for academia, biopharma and regulated clinical laboratories.

Insightful Science Acquires LabArchives

November 10, 2021

Software

Insightful Science, a portfolio company of Insight Partners, has completed the acquisition of LabArchives, a widely used electronic lab notebook (ELN) and lab informatics SaaS platform. The deal expands Insightful Science's cloud-based R&D product portfolio—adding ELN/LIMS capabilities used by academic, non-profit and commercial research organizations.

OncoCyte Corporation Acquires Insight Genetics

January 10, 2020

Healthcare Services

OncoCyte Corporation agreed to acquire all outstanding capital stock of Insight Genetics, a privately held molecular diagnostics company, for approximately $12 million in cash and stock plus potential contingent payments. The acquisition adds Insight Genetics' IM Score immuno-oncology diagnostic test and a pharma-trial–capable CLIA/CAP lab to OncoCyte's portfolio to expand its capabilities in oncology diagnostics and pharma services.

iCapital Network Acquires AI Insight

January 21, 2021

Financial Services

iCapital Network has agreed to acquire the assets of AI Insight, Inc., an education and compliance platform that provides fund-specific research, training and credentialing for financial advisors focused on alternative investments. As part of the transaction, AI Insight’s executives Sherri Cooke and Jennifer Simon and eight additional employees are expected to join iCapital to integrate AI Insight’s learning management system into iCapital’s advisor-facing alternative investment platform.